SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

J&J Says Phase 4 TREMFYA Study Met Key Endpoints in Axial PsA

TREMFYA showed statistically significant improvement versus placebo in axial psoriatic arthritis, according to the supplied report.

JNJ

Related stories